OTHER
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma (Adv. Sci. 24/2021)
Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh‐Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding
- Year
- 2021
- Citations
- 2
Abstract
CRISPR Nanotheranostics In article number 2102051, Yeh‐Hsing Lao, Qi Zhang, Yu Tao, Mingqiang Li, and co‐workers overview the recent advances of CRISPR nanotheranostics in tacking viral hepatitis and hepatocellular carcinoma. The nanoscale CRISPR/Cas systems could act as smart enzymatic robots to target the disease‐associated cells and nucleic acid signatures and may be potentially added to the armamentarium for efficiently addressing these challenging liver diseases. [Image: see text]
Keywords
CRISPRHepatocellular carcinomaHepatitis virusVirologyViral hepatitisHepatitis a virusMedicineHepatitisBiologyCancer research
Related papers
OTHER
📊 26,957 cites
Statistical Learning Theory
Yuhai Wu, Vladimir Vapnik
1999
OTHER
Open access📊 20,501 cites
Fractional Differential Equations
Igor Podlubný
2025
OTHER
📊 18,993 cites
Applied Nonlinear Control
Jean-Jacques Slotine, Weiping Li
1991
OTHER
📊 13,277 cites
Genetic Programming: On the Programming of Computers by Means of Natural Selection
John R. Koza
1992